$ 192.6
Key Takeaways
Risk factor
Low price volatility
Profitability factor
Very low or no dividends
About
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers...
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITDA, underpriced on P/
Target Price
The average target price of ICLR is 220 and suggests 15% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation s
